Latest Drug Safety news
FDA Panel Backs Two Peptides For Compounding, Rejects One
posted July 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
posted July 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds
posted June 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy Related Articles
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs Monthly Specialist Briefings
Stay Connected
